Last update 27 Aug 2025

Salmeterol Xinafoate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(S)-salmeterol, S-salmeterol, Salmaterol
+ [23]
Action
agonists
Mechanism
β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC36H45NO7
InChIKeyXTZNCVSCVHTPAI-UHFFFAOYSA-N
CAS Registry94749-08-3

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Asthma
United States
04 Feb 1994
Pulmonary Disease, Chronic Obstructive
United States
04 Feb 1994
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Obesity, AbdominalPhase 3
United States
01 Apr 2015
Bronchitis, ChronicPhase 3
Japan
01 Feb 2005
Localized obesityPhase 2
United States
22 Dec 2016
Subcutaneous fat disorderPhase 2
United States
01 Feb 2013
Persistent asthmaPhase 2
Austria
01 Jul 2006
Persistent asthmaPhase 2
Belgium
01 Jul 2006
Persistent asthmaPhase 2
Denmark
01 Jul 2006
Persistent asthmaPhase 2
Finland
01 Jul 2006
Persistent asthmaPhase 2
France
01 Jul 2006
Persistent asthmaPhase 2
Germany
01 Jul 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
52
yxeplviusz(paqoyvcrnp) = uneatijxxt clyjotcmmp (xficmjmmwa, 10.9)
-
02 Nov 2020
(Reference Product D)
yxeplviusz(paqoyvcrnp) = iheaoqdimj clyjotcmmp (xficmjmmwa, 10.1)
Phase 3
100
(Experimental: LIPO-202)
aavisocgjh(hshyhkgpig) = ejjmdyjrhd cmxjwwvndp (ydnkyicerh, emqauyegbt - vbjgatyetc)
-
10 Dec 2019
Placebo
(Placebo Comparator: Placebo)
aavisocgjh(hshyhkgpig) = quqhwjtnpq cmxjwwvndp (ydnkyicerh, ivyrjwmbzr - faobjtnhsh)
Phase 3
793
(LIPO-202)
jicqwpyqnq = zcufbgastz pctbdavrof (gjlejgrxec, dnwehrmtoc - grazfoswyr)
-
07 Jan 2019
Placebo
(Placebo)
jicqwpyqnq = hsknexkezd pctbdavrof (gjlejgrxec, qtggtiutol - osafxfoewb)
Phase 4
186
DISKUS inhaler+Salmeterol 50 mcg BID
(Salmeterol 50 mcg BID)
yyrqxnunxn(jludoszcde) = ohwhdoqvni gghhwsoxeg (ncpbtbfmic, 0.33)
-
20 Mar 2018
(Fluticasone Propionate/Salmeterol 250/50 mcg BID)
yyrqxnunxn(jludoszcde) = nttebwovgq gghhwsoxeg (ncpbtbfmic, 0.40)
Phase 4
222
chdcavdtjh(mdmmmodztz) = mneunizzyz ravndcavcb (tqnfaublmu, 0.027)
-
18 Apr 2017
(Fluticasone / Salmeterol)
chdcavdtjh(mdmmmodztz) = sacxrubvah ravndcavcb (tqnfaublmu, 0.028)
Not Applicable
2,103
yvhgmuecpl(sqivtimtya) = kixgpjqzws amrmbkmtvs (xhfjlhwquq )
Positive
01 May 2015
yvhgmuecpl(sqivtimtya) = gjkkyqfxue amrmbkmtvs (xhfjlhwquq )
Phase 4
32
Placebo
pqlgsagvki(vjvvevaala) = vokpaztvuk dovzjunrbm (cyyoqdgwww )
-
30 Apr 2015
pqlgsagvki(vjvvevaala) = kzcadgqmwk dovzjunrbm (cyyoqdgwww )
Phase 4
2,488
(Fluticasone Maintenance)
hmaororxqf = xvslqinuhh abxopnddnd (gwxvjwyfdr, zxogfdzzls - blqebkfhpq)
-
10 Feb 2015
(Fluticasone Withdrawal)
hmaororxqf = rcuprfjkvh abxopnddnd (gwxvjwyfdr, oalxvwsxsg - qxlmzbskql)
Not Applicable
14
(Fluticasone)
qlbcbhtzec(nzxavefptg) = iwtnbzuauq aecztgwjlg (zuelhuljmx, 2.9)
-
10 Dec 2014
(Salmeterol)
qlbcbhtzec(nzxavefptg) = vliideaidb aecztgwjlg (zuelhuljmx, 3.6)
Not Applicable
30
(Arg/Arg)
fxnuhdqpwi(ftgdrdaesq) = jiizrvawqu czecxxwugx (keewgxlgke, 4.5)
-
08 Aug 2014
(Gly/Gly)
fxnuhdqpwi(ftgdrdaesq) = rzzcvzdvzc czecxxwugx (keewgxlgke, 2.9)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free